DIS vs NBIX · P/E 16, rev $94.42B vs P/E 45, rev $1.77B
Walt Disney Company (DIS) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Walt Disney Company (DIS) is a entertainment company listed on NYSE. It is led by Bob Iger.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DIS revenue for 2025-09-27 was $94.42B. Net income was $12.40B. DIS currently screens at market cap $175.14B and trailing P/E 16.1.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
DIS currently screens at market cap $175.14B and trailing P/E 16.1. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the DIS and NBIX stock pages for the full models.
Not investment advice.